Moderna and Merck, the firms behind the vaccine, are rushing through trials on other tumours. In coming years the results of these, and full results of the melanoma trial, will allow assessment of the scale of the breakthrough
View on Bluesky
Source: at://did:plc:kkf4naxqmweop7dv4l2iqqf5/app.bsky.feed.generator/news-2-0
Author: The Economist (@economist.com)
View on Bluesky
Source: at://did:plc:kkf4naxqmweop7dv4l2iqqf5/app.bsky.feed.generator/news-2-0
Author: The Economist (@economist.com)